We integrate pancreatobiliary endoscopy with interventional endoscopic ultrasound (EUS) to treat biliary and pancreatic diseases. Cholangioscopy- and pancreatoscopy-guided lithotripsy enable treatment of difficult stones. Our team provides specialist on-call support 24 hours a day for timely care.
For stones in the bile duct, cystic duct or pancreatic duct, we combine endoscopic retrograde cholangiopancreatography (ERCP) with direct visualization using cholangioscopy or pancreatoscopy. Electrohydraulic lithotripsy (EHL) treats large, impacted stones or stones that are difficult to remove with conventional techniques. When ERCP fails or surgically altered anatomy limits access, interventional EUS can establish an access route for lithotripsy, reducing the need for surgery in selected patients. EUS enables tissue sampling of pancreatic tumors. EUS-guided interventions include drainage of pancreatic fluid collections, gallbladder drainage for acute cholecystitis, biliary and pancreatic duct drainage, and gastroenterostomy. Specialists provide on-call coverage throughout the year, working with emergency medicine, anesthesia, surgery and diagnostic imaging teams. Our 24-hour specialist service coordinates emergency treatment and follow-up. Assessment begins through the Emergency Department or an inpatient consultation.
Difficult Stones
For stones in the bile duct, cystic duct or pancreatic duct, we combine endoscopic retrograde cholangiopancreatography (ERCP) with direct visualization using cholangioscopy or pancreatoscopy. Electrohydraulic lithotripsy (EHL) treats large, impacted stones or stones that are difficult to remove with conventional techniques. When ERCP fails or surgically altered anatomy limits access, interventional EUS can establish an access route for lithotripsy, reducing the need for surgery in selected patients.
Interventional Treatment
EUS enables tissue sampling of pancreatic tumors. EUS-guided interventions include drainage of pancreatic fluid collections, gallbladder drainage for acute cholecystitis, biliary and pancreatic duct drainage, and gastroenterostomy.
Emergency Care
Specialists provide on-call coverage throughout the year, working with emergency medicine, anesthesia, surgery and diagnostic imaging teams. Our 24-hour specialist service coordinates emergency treatment and follow-up. Assessment begins through the Emergency Department or an inpatient consultation.
Clinical Endoscopy. 2025;58:201–217. DOI: 10.5946/ce.2024.206 A review from our department on interventional EUS: techniques and experience in managing complications.
BMC Gastroenterology. 2022;22:243. DOI: 10.1186/s12876-022-02325-7 Our institution’s capabilities in pancreatic cancer research, risk assessment, and clinical studies.
Scientific Reports. 2022;12:107. DOI: 10.1038/s41598-021-04095-w Research on pancreatic cancer and probiotics.
Symbol of National Quality (SNQ)
2023 Symbol of national Quality (S010297). Pancreaticobiliary Endoscopy Team: Unique Interventional ERCP Training Center in Taiwan.
Pancreatobiliary Endoscopy Team: Wen-Hsin Huang, Chi-Ying Yang, Shih-Chieh Chuang, Cheng-Hsing Hung, Tsung-Lin Hsieh, Yu-Chen Chang, Chin-Wei Chang
Outpatient Appointments: Visit the hospital website, select “Online Appointment Booking,” and choose Digestive Medicine and an appropriate physician. Referrals: Please use the hospital’s referral service. Patients with fever accompanied by jaundice or significant gastrointestinal bleeding should seek care at the Emergency Department. The team will arrange treatment according to the patient’s clinical condition.
Digestive Medicine and AppointmentsDigestive Medicine TeamCapsule endoscopy and double-balloon enteroscopy are used for disease localization and diagnosis—enabling precise small bowel lesion localization, histological diagnosis, and minimally invasive therapy—combined with intestinal ultrasound to evaluate early treatment response in small bowel lesions and inflammatory bowel disease (IBD).
For obscure gastrointestinal bleeding, small bowel tumors, and Crohn's disease, capsule endoscopy is utilized to localize lesions, followed by deep enteroscopy for biopsy, hemostasis, and lesion-specific interventions. Intestinal ultrasound provides radiation-free, repeatable evaluations of the bowel wall and surrounding tissues, facilitating the assessment of inflammation severity and early treatment response. By integrating endoscopy, imaging, pathology, surgery, and nutritional care, follow-up plans are tailored to specific disease characteristics, establishing a continuum of care that encompasses diagnosis, treatment, and long-term disease monitoring.
Lesion Localization
Capsule endoscopy is utilized to localize lesions.
Targeted Intervention
Deep enteroscopy for biopsy, hemostasis, and lesion-specific interventions.
Ongoing Monitoring
Radiation-Free, Repeatable, Real-Time Assessment
Advances in Digestive Medicine. 2026;13:e70016. DOI: 10.1002/aid2.70016 A study conducted at our hospital integrating biomarkers and intestinal ultrasound for the assessment of disease activity.
JGH Open. 2022;6:63–68. DOI: 10.1002/jgh3.12697 Single-Center Study: Clinical Experience in Diagnosing Etiologies of Small Bowel Bleeding via Deep Enteroscopy.
Symbol of National Quality (SNQ)
2025 Symbol of national Quality (S010980). Comprehensive Medical Care for Patients with Inflammatory Bowel Disease.
IBUS Module 2 International Training Center
2026 IBUS Module 2 International Training Center. Qualification: Intestinal Ultrasound Education and Training.
Small Bowel Team: Jen-Wei Chou, Yi-Hua Wu, Po-Ju Huang
Intestinal Ultrasound: Tsung-Yu Tsai
Outpatient Appointments: Visit the hospital website, select “Online Appointment Booking,” and choose Digestive Medicine and an appropriate physician. Referrals: Please use the hospital’s referral service. Patients with fever accompanied by jaundice or significant gastrointestinal bleeding should seek care at the Emergency Department. The team will arrange treatment according to the patient’s clinical condition.
Digestive Medicine and AppointmentsDigestive Medicine TeamBy integrating Sonazoid contrast-enhanced ultrasonography, CT/MRI–ultrasound fusion imaging, and radiofrequency and microwave ablation, we provide precision, minimally invasive treatment for liver tumors. Anesthesiologist-managed sedation and intraoperative monitoring enhance patient comfort, while emphasizing preservation of liver function and comprehensive follow-up care.
China Medical University Hospital integrates Sonazoid contrast-enhanced ultrasonography (CEUS), CT/MRI–ultrasound fusion imaging guidance, and radiofrequency ablation (RFA) and microwave ablation (MWA) to facilitate precise identification, localization, and individualized treatment planning for liver tumors. Treatment strategies are tailored by a multidisciplinary hepatology team according to liver cancer stage, tumor size and location, and underlying liver function. Anesthesiologists provide sedation and continuous intraoperative monitoring to enhance patient comfort and minimize procedural discomfort. Following treatment, patients receive comprehensive care incorporating imaging surveillance, monitoring for tumor recurrence, liver function management, and coordinated multidisciplinary treatment when indicated. This integrated approach supports continuity of care and long-term liver health.
Enhanced Visualization
Provides additional imaging information during the vascular and Kupffer phases, facilitating accurate detection and localization of liver lesions.
Image-Guided Localization
Integrates preprocedural CT/MRI images with real-time ultrasonography to improve localization of liver lesions that are difficult to visualize using conventional ultrasound alone.
Minimally Invasive Treatment
Individualized local ablation strategies based on tumor size, location, number of lesions, and underlying liver function.
Anesthesia Care
Sedation and continuous intraoperative monitoring provided by anesthesiologists to enhance patient comfort and minimize procedural pain and discomfort.
Important Safety Information: The term “painless sedation anesthesia” is used by our hospital to describe its anesthesia services. The actual anesthesia technique is individualized according to each patient's clinical condition and risk assessment. Complete freedom from pain or complications cannot be guaranteed.
American Journal of Cancer Research. 2020;10(12):4547–4560. PMID: 33415018 Identification of predictors associated with immunotherapy response and survival in patients with unresectable hepatocellular carcinoma (HCC).
Cancers. 2021;13(15):3758. DOI: 10.3390/cancers13153758 Demonstration of the prognostic value of on-treatment albumin-bilirubin (ALBI) grade for predicting treatment response and clinical outcomes during sequential targeted therapy.
American Journal of Cancer Research. 2021;11(12):6173–6187. PMID: 35018250 Evaluation of dynamic alpha-fetoprotein (AFP) response as a biomarker for predicting treatment outcomes in patients receiving immune checkpoint inhibitor–based therapy.
Journal of Gastrointestinal Oncology. 2024;15(5):2216–2229. DOI: 10.21037/jgo-24-351 Assessment of real-world clinical outcomes associated with lenvatinib-based targeted therapy and combination treatment strategies in patients with advanced HCC.
These publications reflect the liver cancer team’s research in treatment strategies, risk stratification, and real-world outcomes. They do not constitute a direct institutional comparison of RFA and MWA outcomes.
Local Ablation: Hung-Wei Wang, Wei-Fan Hsu
Digestive Medicine and Multidisciplinary Liver Cancer Team: Hung-Wei Wang, Wei-Fan Hsu, Tzu-Hao Yen
Outpatient Appointments: Visit the hospital website, select “Online Appointment Booking,” and choose Digestive Medicine and an appropriate physician. Referrals: Please use the hospital’s referral service. Patients with fever accompanied by jaundice or significant gastrointestinal bleeding should seek care at the Emergency Department. The team will arrange treatment according to the patient’s clinical condition.
Digestive Medicine and AppointmentsDigestive Medicine Team